Terms: = Cervical cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Diagnosis
7 results:
1. Delayed cervical cancer diagnosis: a systematic review.
Allahqoli L; Dehdari T; Rahmani A; Fallahi A; Gharacheh M; Hajinasab N; Salehiniya H; Alkatout I
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8467-8480. PubMed ID: 36459029
[TBL] [Abstract] [Full Text] [Related]
2. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, timp-1, timp-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
[TBL] [Abstract] [Full Text] [Related]
3. Plasma Levels and Tissue Expression of Selected Cytokines, Metalloproteinases and Tissue Inhibitors in Patients With cervical cancer.
Sidorkiewicz I; Piskór B; Dąbrowska E; Guzińska-Ustymowicz K; Pryczynicz A; Zbucka-Krętowska M; Ławicki S
Anticancer Res; 2019 Nov; 39(11):6403-6412. PubMed ID: 31704874
[TBL] [Abstract] [Full Text] [Related]
4. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of cervical cancer Based on ROC Analysis.
Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
[TBL] [Abstract] [Full Text] [Related]
5. [Interstitial collagenase and their endogenous regulators in squamous cell cervical carcinoma].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Solovyeva NI
Biomed Khim; 2017 Nov; 63(6):513-519. PubMed ID: 29251612
[TBL] [Abstract] [Full Text] [Related]
6. [Progress of clinical pathology and application of PET-CT on thyroid carcinoma].
Gao M; Li XL; Yu Y; Sun BC; Li SL; Xu WG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jun; 41(6):419-24. PubMed ID: 16927796
[TBL] [Abstract] [Full Text] [Related]
7. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
Davidson B; Goldberg I; Liokumovich P; Kopolovic J; Gotlieb WH; Lerner-Geva L; Reder I; Ben-Baruch G; Reich R
Int J Gynecol Pathol; 1998 Oct; 17(4):295-301. PubMed ID: 9785129
[TBL] [Abstract] [Full Text] [Related]